New Purdue bankruptcy plan roundly criticized as Sacklers offer $4B+; Sana seals pact with Fujifilm for iPSC-derived therapies
Members of the Sackler family caught up in thousands of lawsuits targeting them and Purdue Pharma for their involvement in the opioid epidemic have agreed to hand over $4.3 billion of their fortune in exchange for being left off the hook of litigation.
That figure marks a significant increase over the $3 billion that had been on offer, and it was immediately attacked by a host of critics who believe they should be required to give up much, much more after profiting from the reckless distribution of OxyContin. The opioid epidemic is responsible for the deaths of hundreds of thousands of people.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.